Drugs that cost as much as a house are on the way to treat rare and devastating diseases. The US is scrambling to figure out how to pay for them.

Posted On // Leave a Comment
 
Learn more about BI Prime View online
 
 
 
BUSINESS INSIDER
 
 
Science Select
 
 
 
Drugs that cost as much as a house are on the way to treat rare and devastating diseases. The US is scrambling to figure out how to pay for them.
 
 
Drugs that cost as much as a house are on the way to treat rare and devastating diseases. The US is scrambling to figure out how to pay for them.
 
The cost of gene therapies will put a huge financial strain on the US health system as new products become available to treat more common diseases.
 
 
 
 
 
NASA's newest planet-hunting telescope just discovered a 'super-Earth' and 2 'sub-Neptunes' less than 75 light-years away — among the closest exoplanets ever found
 
 
NASA's newest planet-hunting telescope just discovered a 'super-Earth' and 2 'sub-Neptunes' less than 75 light-years away — among the closest exoplanets ever found
 
TESS, the space telescope searching for alien worlds, has discovered three nearby exoplanets that could offer clues about how planets form.
 
 
 
 
 
CVS wants to change where millions of Americans go when they get sick. Here's how it plans to get them in the door in the first place.
 
 
CVS wants to change where millions of Americans go when they get sick. Here's how it plans to get them in the door in the first place.
 
CVS's marketing chief is working to change why customers come into the pharmacy, balancing what customers want to buy with what's good for them.
 
 
 
 
 
 
A spectacular meteor shower is coming — here's what you're actually seeing
 
 
A spectacular meteor shower is coming — here's what you're actually seeing
 
From the Perseids in August to the Leonids in November, meteor showers are light shows we can count on each year. Here's what you're actually seeing.
 
 
 
 
 
Aetna will now pay for more kids with a devastating rare disease to get a $2.1 million drug, reversing earlier denials
 
 
Aetna will now pay for more kids with a devastating rare disease to get a $2.1 million drug, reversing earlier denials
 
Business Insider's reporting highlighted families fighting for access to the treatment, Zolgensma, which is the most expensive drug in the world.
 
 
 
 
 
The Trump administration wants you to know how much your medical procedures will cost — and hospitals are up in arms
 
 
The Trump administration wants you to know how much your medical procedures will cost — and hospitals are up in arms
 
The Trump adminstration said it wants to make public information about the prices hospitals set and the prices they negotiate with health insurers.
 
 
 
 
 
The $1.2 trillion pharma industry has ambitions for AI technology, but 'people are ignoring' a lot of its uses
 
 
The $1.2 trillion pharma industry has ambitions for AI technology, but 'people are ignoring' a lot of its uses
 
AI is being explored across the healthcare industry to drive faster drug discovery and more effective clinical trials.
 
 
 
 
 
Facebook says it's one step closer to its vision of letting people type with their brains
 
 
Facebook says it's one step closer to its vision of letting people type with their brains
 
For the first time, researchers at UCSF were able to take the brain activity of participants and simultaneously decode what was being said.
 
 
 
 
 
$11 billion drugmaker Mylan and US drug giant Pfizer are teaming up to reshape Mylan's business. 3 tough questions from Wall Street analysts show the challenging road ahead.
 
 
$11 billion drugmaker Mylan and US drug giant Pfizer are teaming up to reshape Mylan's business. 3 tough questions from Wall Street analysts show the challenging road ahead.
 
Wall Street analysts asked big questions about the new company's future. Execs occasionally got testy.
 
 
 
 
 
The 'lungs of the planet' are in danger of reaching a tipping point that could turn the Amazon rainforest into a savannah
 
 
The 'lungs of the planet' are in danger of reaching a tipping point that could turn the Amazon rainforest into a savannah
 
Deforestation in the Amazon rainforest has broken records in July. Scientists warn that, after a point, the Amazon might not be able to recover.
 
 
 
 
 
 
 
Was this email forwarded to you?
 
Download on the app store   Get it on google play
 
Share this
 
fb   tw   g+
 
You received this email because you signed up to this
Business Insider newsletter using the
email: nguyenvu1187.love5@blogger.com
 
Email preferences Unsubscribe
TERMS OF SERVICE PRIVACY POLICY
1 Liberty Plaza, 8th Floor. New York, NY 10006
 

0 comments:

Post a Comment